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OPEN
ORIGINAL ARTICLE
Molecular epidemiology of human enterovirus 71 at the
origin of an epidemic of fatal hand, foot and mouth
disease cases in Cambodia
Veasna Duong1, Channa Mey1, Marc Eloit2, Huachen Zhu3, Lucie Danet1, Zhong Huang4, Gang Zou4,
Arnaud Tarantola1, Justine Cheval5, Philippe Perot2, Denis Laurent6, Beat Richner6, Santy Ky6, Sothy Heng6,
Sok Touch7, Ly Sovann7, Rogier van Doorn8, Thanh Tan Tran8, Jeremy J Farrar8, David E Wentworth9,
Suman R Das9, Timothy B Stockwell9, Jean-Claude Manuguerra2, Francis Delpeyroux2,10, Yi Guan3,
Ralf Altmeyer4 and Philippe Buchy1,11
Human enterovirus 71 (EV-A71) causes hand, foot and mouth disease (HFMD). EV-A71 circulates in many countries and has
caused large epidemics, especially in the Asia-Paciﬁc region, since 1997. In April 2012, an undiagnosed fatal disease with
neurological involvement and respiratory distress occurred in young children admitted to the Kantha Bopha Children’s Hospital
in Phnom Penh, Cambodia. Most died within a day of hospital admission, causing public panic and international concern.
In this study, we describe the enterovirus (EV) genotypes that were isolated during the outbreak in 2012 and the following year.
From June 2012 to November 2013, 312 specimens were collected from hospitalized and ambulatory patients and tested by
generic EV and speciﬁc EV-A71 reverse transcription PCR. EV-A71 was detected in 208 clinical specimens while other EVs were
found in 32 patients. The VP1 gene and/or the complete genome were generated. Our phylogenetic sequencing analysis
demonstrated that 80 EV-A71 strains belonged to the C4a subgenotype and 3 EV-A71 strains belonged to the B5 genotype.
Furthermore, some lineages of EV-A71 were found to have appeared in Cambodia following separate introductions from
neighboring countries. Nineteen EV A (CV-A6 and CV-A16), 9 EV B (EV-B83, CV-B3, CV-B2, CV-A9, E-31, E-2 and EV-B80) and
4 EV C (EV-C116, EV-C96, CV-A20 and Vaccine-related PV-3) strains were also detected. We found no molecular markers of
disease severity. We report here that EV-A71 genotype C4 was the main etiological agent of a large outbreak of HFMD and
particularly of severe forms associated with central nervous system infections. The role played by other EVs in the epidemic
could not be clearly established.
Emerging Microbes & Infections (2016) 5, e104; doi:10.1038/emi.2016.101; published online 21 September 2016
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INTRODUCTION
Enteroviruses (EVs) belong to the genus Enterovirus within the family
Picornaviridae, which are small non-enveloped, single-stranded posi-
tive-sense RNA viruses with a genome of 7500 bases.1 Human
enteroviruses (HEV) are classiﬁed into three main species: EV-A,
EV-B, EV-C, and other less common EV D-J species.1,2 Human
enterovirus 71 (EV-A71) belongs to the EV-A species, which along
with other EVs can cause hand, foot and mouth disease (HFMD).3
EV-A71 was ﬁrst isolated in California in 1969,4 although it was
suggested that the virus may have circulated in the Netherlands as
early as 1963.5 EV-A71 is present in most countries. Large-scale
epidemics, however, have been observed in Asia-Paciﬁc since 1997.
EV-A71 has become endemic in this region, with regular emergences
of new genetic lineages.6
Sequencing of the P1 coding region for capsid proteins is well
correlated with the previous deﬁnition of serotype. The highly variable
sequences of the EV-A71 VP1 gene have been used to group EV-A71
isolates into four genotypes (A, B, C and D).7,8 EV strains of the same
genotype have 492% nucleotide sequence identity, whereas isolates
with a diversity of 415% are considered as different genotypes.9 The
A group consists of viruses isolated in the United States of America in
1969, including the prototype BrCr strain.4 Genotype B has ﬁve
subgenotypes and has been circulating in Asia, particularly in Malaysia
and Singapore, since the 1970s.10 Subgenotype B5 was reported during
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recent outbreaks in Thailand,11,12 Taiwan13,14 and Vietnam.15 Geno-
type C also comprises ﬁve subgenotypes. C1 emerged in the
mid-1980s10 and replaced genotype B as the predominant genotype
in Europe and America.10 Subgenotype C2 emerged in 1995 in
Australia and the United States of America.10 The C3 subgenotype
emerged in Korea and Japan.16,17 C4 has circulated predominantly in
China since 2000 and is present in many other Asian countries.18–21
The C5 subgenotype was reported in Japan, Vietnam and Taiwan.20,22
Other less frequent EV-A71 genotypes (D–J) have been isolated in
India, Africa and Madagascar.23
In recent years, numerous HFMD outbreaks were reported in Asian
countries, including China, Vietnam, Singapore, South Korea and
Thailand.24 In April 2012, an undiagnosed fatal disease with neuro-
logical involvement and respiratory failure was detected at Kantha
Bopha Children’s Hospital in Phnom Penh, Cambodia. Most of the
children who were affected were aged below three years and mainly
originated from the southern and central parts of the country.25 Most
of them died (56/61 cases), usually within a day after admission to the
hospital.25 Etiological and epidemiological investigations were initiated
in June 2012 after the ﬁrst series of clinical samples were submitted to
the Virology Unit at Institut Pasteur in Cambodia (IPC), Phnom
Penh, Cambodia. EV-A71 followed by other non-EV-A71 EVs were
the microorganisms that were most commonly detected in these
patients.26 The present study aims to describe the EV genotypes that
were isolated during the outbreak in 2012 and 2013.
MATERIALS AND METHODS
Sample collection
From June 2012 to November 2013, clinical specimens such as throat,
nasopharyngeal and rectal swabs, cerebrospinal ﬂuid (CSF), bronch-
oalveolar lavage and sera were collected from hospitalized patients and
outpatients at Kantha Bopha Hospital in Phnom Penh and Jayavarman
VII Hospital in Siem Reap (Northwest Cambodia).
Patients who were admitted to the two hospitals with signs and
symptoms of EV infection (i.e., all patients hospitalized with severe
disease as well as some patients randomly selected in the outpatient
ward presenting with mild disease) were classiﬁed into the following
three main clinical categories: HFMD, HFMD with central nervous
system involvement (CNSI) alone and HFMD with cardiopulmonary
failure (CPF). All patients in the CPF group also experienced CNSI.27
The patient demographic data, clinical symptoms, diagnostic test
results and medical imaging ﬁndings were collected by the clinical
team. Because the initial series of samples used in this study were
collected for diagnostic purposes and characterization of the micro-
organism involved in an outbreak setting, approval was not sought
from the National Ethics Committee. Once the causative agent was
identiﬁed, patients with encephalitis were included in an ongoing
study on the etiology of pediatric encephalitis; this study was approved
by the National Ethics Committee (approval no. 107NECHR).
Additional authorization was obtained to include the outpatients
presenting with HFMD (approval no. 0059NECHR). For all patients,
a signed informed consent was obtained from their guardians before
inclusion.
EV-A71 diagnosis
Diagnostic reverse transcription PCR (RT-PCR). RNA was extracted
from 140 μL of rectal, throat and nasopharyngeal swabs collected in
viral transport medium, serum and CSF using the QIAamp Viral RNA
Mini Kit (Qiagen1, Hilden, Germany) according to the manufacturer’s
recommendations.
A speciﬁc real-time RT-PCR assay was used for the detection of EV-
A71 as described elsewhere.28 Brieﬂy, ﬁve μL of RNA was reverse-
transcribed and ampliﬁed using the SuperScript III Platinum One-Step
qRT-PCR Kit (Invitrogen, Carlsbad, CA, USA) in a mixture of 10 μL
of 2 × Reaction Mix with ROX, 10 μM forward primer (EV71-VP1-
634F: 5′-GGA GAA CAC AAR CAR GAG AAA GA-3′), 10 μM reverse
primer (EV71-VP1-743R: 5′-ACT AAA GGG TAC TTG GAC
TTV GA-3′), 10 μM of EV-A71-speciﬁc probe (EV71-VP1-TaqMan:
5′-FAM-TGA TGG GCA CGT TCT CAG TGC G-BHQ1-3′) and
one μL of SuperScript III RT/Platinum Taq Mix. Molecular-grade
water was added to the reaction to obtain a ﬁnal volume of 20 μL.
Thermocycling was conducted as follows: reverse transcription
at 50 °C for 30 min, then holding at 95 °C for 2 min, followed by
40 cycles of 95 °C for 15 s, 55 °C for 30 s and 72 °C for 20 s.
The samples that tested negative for EV-A71 were further investi-
gated using pan-EV real-time RT-PCR adapted from Beld et al.,29
using a few modiﬁcations for the detection of other HEVs. Speciﬁcally,
the RT step was performed prior to TaqMan real-time PCR. The
extracted RNAs were reverse-transcribed using random hexamers. The
RT was conducted by adding seven μL of RNA into a mixture
containing 1500 ng of random hexamers and 10 mM of each
deoxynucleoside triphosphate. Molecular-grade water was added to
obtain the ﬁnal volume of 12 μL. After incubation for ﬁve min at 60 °C
and one min on ice, seven μL of the second mix (containing 4 μL of
5× buffers, 0.1 M of DTT, 40 U of RNaseOut and ﬁve U of Super-
Script III Reverse Transcriptase (Invitrogen) and 1.4 μL of molecular-
grade water) was added to the ﬁrst mixture. The second mixture was
incubated at 25 °C for 10 min, at 50 °C for one h and at 72 °C for
15 min.
Virus isolation. Patient’s samples were inoculated onto Vero E6 cells.
Brieﬂy, 150 μL of CSF, 20 μL of sera or 100 μL of rectal, nasophar-
yngeal and throat swab samples collected in viral transport medium
were added to 80% conﬂuent Vero E6 cells in a 12-well plate. After
incubating for 1 h at 37 °C with 5% CO2, 1.7 mL of maintenance
medium (Dulbecco’s Modiﬁed Eagle Medium+2% of heat inactivated
fetal calf serum and 1% of Penicillin–Streptomycin (Sigma-Aldrich,
Saint Louis, MO, USA)) was added to each well. The plate was then
incubated for seven days with the same incubation conditions.
The presence of the virus in the supernatant was revealed by the
diagnostic real-time PCR method described above.
Sequencing of EV-A71
Sequencing of the VP1 gene. RNA from the PCR-positive cell culture
supernatants was extracted using the QIAamp Viral RNA Mini Kt
(Qiagen, Hilden, Germany) and the VP1 gene was sequenced using
the primers described by Nix et al.30 DNA sequencing was performed
in a commercial facility using an ABI 3730XL Analyzer (96-capillary)
using the ABI Prism BigDye Terminator Cycle Sequencing Kit
according to the manufacturer’s instructions (Macrogen, Seoul, South
Korea).
Whole-genome sequencing. Whole-genome sequencing of the high-
titrated cell culture supernatants was performed using high-
throughput sequencing. The culture supernatants of two isolates were
clariﬁed by centrifugation at 3500–4000 r for 10 min at 4 °C to remove
the cell debris. They were then ultracentrifuged at 50 000 r.p.m. to
collect the viral pellet. The pellet was resuspended in 140 μL of 10 mM
Tris-Cl buffer (pH 7.5) and treated with RNase, followed by the
addition of 560 μL of prepared AVL Buffer (Qiagen) not containing
carrier RNAs to cleave the viral particles. RNA extraction was
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conducted using the QIAamp Viral RNA Mini Kit (Qiagen) and DNAs
were removed using the RNase-Free DNase Set (Qiagen). Double-
stranded cDNAs were synthesized using the cDNA Synthesis System
(Roche Applied Science, Penzberg, Germany) and random ampliﬁca-
tion of the viral cDNAs was then carried out as previously described.31
Whole-genomic sequencing was conducted on a Genome Sequencer
Junior (Roche Applied Science), and the original reads were assembled
into contigs using Lasergene, version 9.0 (http://www.dnastar.com).
For sample preparation, sequencing and bioinformatic analyses were
conducted as described in Gagnieur et al.,32 except that the human reads
were ﬁltered against NCBI build 37.1/assembly hg19. Each sample was
sequenced with a depth ranging from 67 to 233 million reads each.
Whole-genome sequencing by Sanger method. The total RNA was
extracted from biological samples or cell culture suspension using the
QIAamp Viral RNA Mini Kit (Qiagen) as described above. cDNA was
synthesized from 3 μL of RNA using two μL of each nucleotide
triphosphate (Eurobio, Mannheim, Germany), 10 pmol of each
EV-A71 primer (Supplementary Table S1) and 7.5 μL of sterilized
distilled water. The mixture was incubated at 70 °C for 5 min and then
stored on ice for 2 min. Each tube was then incubated with 1 μL of
SuperScript II Reverse Transcriptase (Invitrogen, Life Technologies) and
0.5 μL of RNasin (Promega, Madison, WI, USA) in a ﬁnal volume of
20 μL for 50 min at 42 °C, then at 95 °C for 5 min and at 4 °C for 1 min.
5 μL of cDNA was then ampliﬁed by sequencing PCR using
10 pmol of paired primers for each EV-A71 fragment
(Supplementary Table S1), one μL of AmpliTaq DNA polymerase
(Applied Biosystems, Carlsbad, CA, USA; Life Technologies), 10 nmol
of each nucleotide triphosphate and 10× taq buffer for a total of 5 μL,
in a ﬁnal volume of 50 μL with H2O added as necessary. The cycling
conditions included initial denaturation at 94 °C for 3 min, 35 cycles
of denaturation at 94 °C for 30 s, annealation at 55 °C for 30 s,
extension at 72 °C for 1 min and ﬁnal extension at 72 °C for 5 min.
The PCR amplicons were sequenced by the Sanger method at a
commercial facility (Macrogen).
All partial VP1 and full-genome sequences generated in this study
were submitted to the GenBank sequence database (NCBI, Bethesda,
MD, USA) with accession numbers as follows: KX197414–KX197422
(EV-A71 VP1), KX197423–KX197454 (Non EV-A71, VP1) and
KX197455–KX197465 (EV-A71 full genome) (Supplementary Table S2).
Sequence analysis and phylogenetic analysis
Sequences generated from the PCR products obtained for each strain
were analyzed and assembled using the CLC Main Workbench 5.5
package (CLC bio A/S, Aarhus, Denmark). The EV-A71 reference
strains consist of 242 sequences of the VP1 gene and 457 full-genome
sequences available in GenBank belonging to two genotypes: B1–B5
and C1–C5. For the phylogenetic analysis of the other EV isolates, 108
VP1 sequences of reference strains, including all four EV species
(A, B, C and D), were used.
A Parechovirus (JX575746) sequence was used as an out-group in
the phylogenetic analysis. Multiple sequence alignment of Cambodian
strains with reference strains available in GenBank was conducted
using Muscle,33 which is available in the Seaview version 4.2.5
package.34 Phylogenetic analyses were performed using the maximum
likelihood method using the GTR model suggested by Jmodeltest,35
which is available in MEGA 5.236 with 1000 bootstrap re-sampling.
Recombination analysis
We used version 3 of the Recombinant Detection Program (RDP 4.56)37
to screen for recombination in our set of EV-A71 full-genome sequence
data. This program implements several methods for the identiﬁcation of
recombinant sequences and recombination breakpoints. Accordingly, we
used the RDP,38 LARD,39 Bootscanning,40 Maxchi,41 Chimaera,42
GeneConv,43 3Seq44 and Sis-scan45 methods, using the default settings
in each case. We only considered recombination events that were
identiﬁed by at least three methods. Statistical signiﬁcance was set to
the Po0.01 level after considering the Bonferroni correction for multiple
comparisons as implemented in RDP.
Statistical analyses
The means of continuous variables and the proportions of the
categorical variables were compared using Student’s t-test, Chi2 test
and Fisher’s exact test as appropriate. Statistical signiﬁcance was set
to 0.05. All statistical analyses were carried out using the Stata
12 statistical software for Windows (StataCorp LP, College Station,
TX, USA).
RESULTS
Patient characteristics and EV genotyping
Between June 2012 and November 2013, 142 cases of HFMD, 20 cases
with CNSI and 150 cases of encephalitis with CPF were recruited by
the two participating hospitals for inclusion in the present study
(Table 1). Among the suspected cases, EV-A71 was detected by either
RT-PCR and/or virus isolation in 96 (67.6%) of the HFMD patients,
11 (55.0%) patients with CNSI and 101 (67.3%) patients with CNSI
associated with CPF. Additionally, co-infection with EV-A71 and non-
EV-A71 was detected in ﬁve cases. This was immediately reported to
the health authorities. The differences in EV-A71 prevalence by disease
severity group were not statistically signiﬁcant (P= 0.389).
The children included in this study were relatively young in all three
clinical groups, with mean ages of 2.18 (95% conﬁdence interval (CI):
1.78–2.58), 2.51 (95% CI: 1.04–4.03) and 2.84 (95% CI: 2.28–3.40)
years in HFMD, CNSI and CPF cases, respectively (Table 1). There
was no signiﬁcant association between the age of the children and the
severity of disease (P= 0.92). However, there were signiﬁcantly more
girls in CPF cases than in HFMD (P= 0.023) except in ‘pure’
encephalitic syndromes (P= 0.33).
The case fatality rate (CFR) was higher among CPF compared with
CNSI cases (63.3% vs 15.0%, Po0.001). No fatalities were reported in
HFMD patients.
Laboratory-conﬁrmed EV-A71 and other EV cases originated from
22 of the 24 Cambodian provinces. Most cases, however, came from
the northwestern (78/240) and southern (98/240) parts of the country.
This pattern corresponds both to the density of the population and to
the catchment area of the two participating hospitals (Supplementary
Figure S1).
Non-EV-A71 viruses were detected in 37 cases (11.9%). Among
these, ﬁve were co-infections with EV-A71. Additionally, ﬁve EVs
detected by generic RT-PCR were unsubtypeable (VP1 sequencing
attempt failed) (Table 1). Of all the non-EV-A71 viruses, EV-A was
the most frequent (59.5%) followed by EV-B (28.0%) and EV-C
(12.5%). The mean age of non-EV-A71 cases was two years (n= 36;
95% CI: 1.54–2.77; range 0.25–7). The sex ratio was 0.76 males per
female.
Phylogenetic analysis
The phylogenetic analysis of the VP1 gene sequence of EV-A71 viruses
was based on 80 sequences from Cambodia. This included nine VP1
sequences in addition to 11 VP1 sequences that were from fully
sequenced strains and that were generated in the present study by
either Sanger or high-throughput sequencing sequencing methods
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(Table 1 and Supplementary Table S1). Additionally, 60 VP1
sequences were from full genomes of Cambodian strains generated
in collaboration with the J. Craig Venter Institute and already available
in GenBank. Phylogenetic analysis showed that all the strains that were
isolated in Cambodia belonged to the C4a subgenotype except for
three strains that clustered closely with the B5 subgenotype (Figure 1).
A phylogenetic analysis of 70 full genomes of Cambodian EV-A71
strains was also conducted (Supplementary Figure S2). However, it did
not demonstrate any signiﬁcant difference compared with the VP1
gene analysis except for minor position changes, all within the same
clusters. Consequently, only VP1 phylogeny will be discussed in this
article. All the 77 Cambodian C4a strains clustered in three different
lineages. Lineage 1 consisted of one strain that was detected in 2012 in
Banteay Meanchey Province (Northwest region, close to the border
with Thailand) that clustered closely to a Thai strain that was isolated
in 2008. Five strains in lineage 2 were detected between 2012 and 2013
and were closely related to viruses originating from China between
2010 and 2012. Lineage 3 consisted of 76 Cambodian strains that were
detected between 2012 and 2013 from different provinces across
Cambodia that clustered with viruses that were isolated in Vietnam in
2011 and 2012. The three Cambodian subgenotype B5 strains were
detected in 2012 in Banteay Meanchey Province (northwest region,
close to the border with Thailand). Of the three B5 strains, two
clustered with strains that were isolated in Thailand in 2011.
One strain clustered with both Vietnamese strains that were isolated
during the 2011–2013 epidemics as well as with Thai strains that were
detected in 2012 (Figure 1).
We did not observe any association between the precise phylogeny
of the Cambodian strains and the severity of disease or the
geographical distribution of cases (data not shown).
There was 97.8% nucleotide identity between the VP1 and/or full-
genome sequences of the Cambodian strains of lineage 1 and Thai
strain FJ556875 THA08. Nucleotide identity of lineage 2 and the
sequences of Chinese viruses isolated from 2010 to 2012 ranged from
97.4% to 99.1%. Nucleotide identity of lineage 3 and the sequences of
the Vietnamese viruses that were isolated in 2011 ranged from 97.4%
Table 1 Patient characteristics and symptoms/clinical signs
Total (n=312) HFMD (n=142)
Central nervous system involvement
(n=20)
Cardiopulmonary failure
(n=150)
Age (years)
Mean (95% CI) 2.51 2.18a (1.78–2.58) 2.51 (1.04–4.03) 2.84b (2.28–3.40)
Median 2 2 1.7 2
Min.–max. 0.16–27 0.75–27 0.91–14 0.16–27
Sex (% female) 134 (42.8%) 52 (36.6%) 8 (40.0%) 74c (50.3%)
Hospitalization
Nod 62 (20.0%) 62 (43.4%) 0 0
Hospitalized 250 (80.0%) 80 (56.6%) 20 (100%) 150 (100%)
Clinical symptoms
Papulovesicular rash 130 (42.4%) 103 (72.0%) 5 (35.7%) 22 (14.7%)
Fatal cases 98 (31.4%) 0 3 (15.0%) 95 (63.3%)
Laboratory diagnostic tests (RT-PCR and/or virus isolation)
EV-A71 208 (66.6%) 96 (67.6%) 11 (55.0%) 101 (67.3%)
Other than EV-A71 32 (10.3%) 18 (12.7%) 5 (25.0%) 9 (6.0%)
Subtyped 27 (73%) 15 5 7
Unsubtypable 5 (13.5%) 3 0 2
Co-infection with EV-A71 and non-EV-A71 5 (1.6%) 1 (0.7%) 0 4 (2.7%)
Negative 67 (21.5%) 27 (19.0%) 4 (20.0%) 36 (24.0%)
Sequencing
EV-A71
VP1 9 3 (33.3%) 4 (44.5%) 2 (22.2%)
Full genome 11 4 (36.5%) 2 (18.0%) 5 (45.5%)
Other than EV-A71
VP1 32 16 (50.0%) 5 (15.6%) 11 (35.4%)
Enterovirus A 18 (56.3%) 14 CV-A6, 1 CV-A16 2 CV-A6, 1 CV-A16
Enterovirus B 7 (21.9%) 0 2 CV-B3, 1 E-2 and 1 EV-B80 1 EV-B83, 1 CV-B2, 1 E-31 and 1 CV-A9
Enterovirus C 2 (6.3%) 0 1 CV-A20 1 EV-C116
Co-infection with EV-A71 5 (15.5%) 1 CV-A6 (A) 0 2 CV-B2 (B), 1 EV-C96 (C) and 1 PV-3 (C)
Abbreviations: enterovirus A, (A); enterovirus B, (B); enterovirus C, (C); conﬁdence interval, CI; coxsackievirus A, CVA; coxsackievirus B, CVB; echovirus, E; enterovirus, EV; human enterovirus 71,
EV-A71; hand, foot and mouth disease, HFMD; poliovirus, P; reverse transcription PCR, RT-PCR; poliovirus E vaccine-related, VRPV.
an=141.
bn=146.
cn=147.
dPatients recruited at the outpatient department.
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to 99.1%. The percentage of homology between the sequences of the
Cambodian B5 subgenotype strains and the corresponding strains of
Vietnamese and Thai origin with which they clustered ranged from
98.7% to 99.6% and from 98.7% to 99.0%, respectively.
Phylogenetic analysis of 32 non-EV-A71 strains demonstrated that
the Cambodian sequences belonged to three EV species (Figure 2),
including 19 strains belonging to EV-A (17 Coxsackievirus (CV) A6
and 2 CV-A16), nine strains belonging to EV-B (1 EV-83, 2 CV-B3, 2
CV-B2, 1 CV-A9, 1 Echovirus (E)-31, 1 E-2 and 1 EV-B80) and four
strains belonging to EV-C (one each of EV-C116, EV-C96, CV-A20
and poliovirus 3). The poliovirus 3 strain had a homology of 499%
with a homologous Sabin vaccine strain and was classiﬁed as
poliovirus vaccine-related. Of all non-EV-A71 viruses, CV-A6 was
detected signiﬁcantly more frequently in mild HFMD cases than in
severe cases (Po0.001), while EV-B and EV-C were only found in the
most severe cases (Po0.001; Table 1). Phylogenetic analysis of the
CV-A6 sequences displayed close genetic relations to CV-A6 strains
that circulated in Thailand and China (Figure 2).
Mutations and recombination
We did not observe any of the known mutations that are associated
with a speciﬁc clinical group. A recombination event was detected by
ﬁve methods (RDP, Genecov, MaxChi, Chimaera and SiScan) in the
RDP software with P-valueo0.001 in one Cambodian EV-A71 strain
(KP308450) collected in 2012. The recombination analysis detected
two breakpoints at nucleotide positions 390 and 3664. The major
parent was HM622391 (detected in Taiwan in 2008) and the minor
parent was EF373576 (Taiwan, 2004) from the same genotype.
No other recombination events were detected in the 2012–2013
Cambodian strains.
Figure 1 Maximum likelihood phylogenetic tree of 269 EV-A71 VP1 sequences. The branches are color-coded according to the location of sample collection
(Cambodia= red, Vietnam=blue, Thailand=purple and China= green). For better clarity, taxon names are not shown, and sequences from other locations
beside the four countries are not color-coded. The sequences isolated from Cambodian patients with different disease categories of severity are marked by
white triangles for hand, foot and mouth disease, white rectangles for central nervous system involvement and black circles for cardiopulmonary failure.
The tree was built using the maximum likelihood method based on the GTR+G4 model. The robustness of nodes was assessed with 1000 bootstrap
replicates. Bootstrap values o70 are not shown.
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DISCUSSION
This work describes the molecular characteristics of the EV-A71
viruses causing the ﬁrst reported outbreak of EV infection with a high
apparent number of severe outcomes in Cambodia between 2012 and
2013. The outbreak of HFMD in early July 2012 was marked by a very
high CFR (92%) among patients at the intensive care units of Kantha
Bopha Children’s Hospitals. This caused panic among the public,
which was abundantly reported by international media and commen-
ted in the scientiﬁc community.25,46,47 This study demonstrates that
EV-A71 was the main etiological agent of the Cambodian outbreak.
The circulation of various non-EV-A71 EV types was also detected.
However, EVs in general are extremely common, especially in
children, and cause a spectrum of usually mild infectious diseases
that are rarely associated with epidemics. Their detection, essentially
by rectal swabs, was therefore most likely not directly related to the
outbreak of severe disease. Most patients originated from the North-
eastern and Southern regions of Cambodia in which the two large
pediatric hospitals participating in the study were located. These
regions may represent a bias and limitation of geographical recruit-
ment, especially as these hospitals provide care free of charge. Similar
to other reports, young children were the most affected age group in
our study with a median age of two years.20,48,49 We also observed that
the proportion of girls was signiﬁcantly higher in the clinically severe
group. In a meta-analysis of 19 separate studies, however, gender was
not a risk factor, whereas young age was a risk factor.50 Indeed,
children aged below two years were often found to be at a higher risk
of developing severe complications.51–53 We did not observe any
difference in median age between the three clinical groups in the
present study. The association of other factors with poor outcomes
will be assessed in another article.
The phylogenetic analysis of 80 Cambodian strains demonstrated
that the viruses clustered in subgenotypes C4a and B5. Subgenotype
C4a has been reported to cause large outbreaks in Asia, including in
China in 2012,54 Vietnam in 201128 and Thailand in 2008–2009.48
Other outbreaks were reported with co-circulation of different
genotypes or subgenotypes and other EVs of species such as in
Vietnam in 2011 with subgenotypes EV-A71 C4 and C5,28 Thailand
with EV-A71, CV-A16 and CV-A1048 and Singapore in which EV-A71
co-circulated with CV-A6, CV-A10, CV-A16 and CV-A4.49 Although
subgenotype B5 was detected in Cambodia in a province bordering
Thailand in 2012, this genotype was not detected subsequently.
Genotype B5 virus was possibly introduced into Cambodia from
neighboring Thailand or Vietnam where this virus circulated pre-
viously and caused outbreaks of HFMD in 201211,12,55 if not earlier,
according to serological studies conducted in Thailand.12 In 2012,
Vietnam experienced a genotype switch from subgenogroup C4 to B5.
Although the switch to B5 was associated with small outbreaks in
Vietnam as in Sarawak (Malaysia) in 2003 and 2006,56 Taiwan
experienced a large outbreak of subgenotype B5 strains in 2008.57
Interestingly, three distinct lineages were identiﬁed in subgenotype
C4. Lineage 1 grouped closely to a Thai strain, lineage 2 was closely
related to Chinese strains and lineage 3 clustered with Vietnamese
Figure 2 Maximum likelihood (ML) phylogenetic tree of 140 VP1 sequences from all four enterovirus species (A, B, C and D). The tree was built using the
ML method based on the GTR+G4 model. The robustness of nodes was assessed with 1000 bootstrap replicates. Bootstrap values o70 are not shown. The
sequences isolated from Cambodian patients with different disease categories of severity are marked by white triangles for hand, foot and mouth disease,
white rectangles for central nervous system involvement and black circles for cardiopulmonary failure.
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strains. Cambodian B5 strains clustered with strains that were detected
previously or concurrently in Thailand and Vietnam. This observation
suggests several separate introductions of EV-A71 viruses from
neighboring countries into Cambodia, in view of the very high
percentage of nucleotide identity (497%) between the Cambodian
strains and those isolated in China, Vietnam and Thailand.
The circulation of viruses between neighboring countries is often
observed with EVs and has been regularly documented in the
past.58–61 Several genotypes (e.g., C1, C4, C5, B5) of EV-A71 and
some non-EV-A71 viruses (e.g., CV-A16) circulated in Vietnam since
2005 and in Thailand since 2008,12,48 with C5 being the predominant
EV-A71 subgenotype.20,28 The reason why HFMD was never detected
or was detected but never reported in Cambodia before 2012 remains
unclear. One of the best hypotheses is that the disease was mis-
diagnosed by clinicians. Indeed, our recent retrospective serological
study using a EV-A71 strain isolated during the 2012 Cambodian
outbreak to detect speciﬁc neutralizing antibodies showed that EV-A71
was widely circulating in the country at least during the preceding
decade, with peaks in 2001, 2005, 2007 and 2010.62 These peaks
coincided with outbreaks that occurred in Vietnam in 200528 and
201120 as well as in China and Taiwan in 2004–2005, 2008 and 2010–
2012.14,53,54,63
During the 2012 outbreak, many severe cases experiencing CPF did
not present the typical rash usually observed in classic HFMD. Indeed,
a papulovesicular rash was observed only in 14.7% of the CPF cases vs
72% in mild HFMD cases. Additionally, most admitted patients were
critical and died within a few hours after admission. This patient
outcome did not provide enough time for clinicians to conduct
extensive diagnostic tests. The high CFR (92%) drew the attention of
clinicians while many mild HFMD cases likely went unnoticed during
the ﬁrst outbreak period.
The high CFR was observed at the beginning of the outbreak in
2012 and then decreased slightly to an average of 63.3% among the
patients presenting with CPF. The CFR in Cambodia was extremely
high compared with that observed in other countries such as in China,
Taiwan and Vietnam, where the CFR ranged from 0.14% to 34%
depending on year, age group and gender.52,64,65 Subgenotype C4a,
which was detected in most Cambodian cases, was already suspected
to both cause more severe disease (CPF) and be associated with higher
lethality.50,52,66–68 We did not ﬁnd any signiﬁcant molecular differ-
ence, however, between EV-A71 subgenotype C4a sequences isolated
from mild HFMD and severe (CNSI and CPF) cases. Similar
observations were also reported by other authors.52,69 There may be
other potential explanations for the severity of EV-A71 infections
reported in Cambodia such as malnutrition, vitamin deﬁcits,
co-infection with other infectious diseases or delay in hospital
admission combined with a lack of speciﬁc intensive care equipment
(such as extracorporeal membrane oxygenation) or intravenous
immunoglobulins.50,70–73 Host genetics may also have a role. Data
to explore these hypotheses were not collected during the outbreak in
2012 and 2013. Further studies to explore the possible role of these
factors would facilitate understanding the unique situation that
Cambodia experienced in 2012. Co-infections involving several EVs
were quite common in HFMD as well as in severe EV-A71
infections.71,74 Four out of the ﬁve co-infections detected in this
study, including the poliovirus vaccine-related EV, were associated
with severe disease.
Recombinations are relatively common in EVs.55,75,76 A single case
of recombination was detected in Cambodia; interestingly, the parent
strain appeared to originate from Taiwan. Studies from Vietnam55 and
Thailand77 also reported a low number of recombination events in
their EV-A71 strains.
In addition to EV-A71, several other EVs were detected in the
various clinical forms of the disease, including CV-A6, which was the
most common of these non-EV-A71 viruses. In our study, CV-A6 was
only associated with mild disease, while EV-A71 was detected in
similar proportions among the three clinical forms. Our CV-A6
ﬁndings are consistent with other reports from the region.49,78–81
CV-A6 progressively became the most common virus detected among
mild HFMD cases, apparently replacing other non-EV-A71 viruses,
including CV-A16 in China, Thailand, Malaysia and Singapore.11,49,82–87
CV-A6 seems now to be associated with many outbreaks worldwide.88
Unfortunately, no recent data regarding the circulation of CV-A6 in
Vietnam is available. EV-B and EV-C species were only detected in
severe (CNSI and CPF) cases. We cannot, however, conﬁrm the
association between these species and disease severity because none of
these viruses were detected in CSF except for one case with CV-B3.
In all other cases, the viruses were detected in other clinical specimens,
especially in rectal swabs (17/32).
In this study, we report the identiﬁcation of the origin of a large
outbreak of EV-A71 and particularly of severe forms of central
nervous system infections associated with fatal CPF. The main
causative agent was EV-A71 genotype C4. The role of non-EV-A71
EVs such as CV-A6 in HFMD outbreaks will be studied further for
potential consideration as a component of new vaccines to prevent
HFMD. Physician training, improved reporting from Cambodian
hospitals and cross-border surveillance should be implemented to
deliver timely adequate care and curb the outbreak. Further study of
the risk factors for severe HFMD, including host genetics, nutritional
status, co-infection and comorbidity, should be investigated in order
to better understand the pathogenesis of this disease.
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